LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,487,527 | -2.7% | 1,123,828 | +0.0% | 9.13% | +0.5% |
Q2 2023 | $77,568,459 | +23.1% | 1,123,692 | -14.0% | 9.09% | +44.6% |
Q1 2023 | $63,007,531 | +7.7% | 1,306,668 | +11.5% | 6.29% | -9.1% |
Q4 2022 | $58,494,659 | -2.2% | 1,171,768 | -20.1% | 6.91% | -20.5% |
Q3 2022 | $59,831,000 | -11.0% | 1,466,453 | +20.0% | 8.69% | -9.9% |
Q2 2022 | $67,229,000 | +68.1% | 1,222,342 | +11.1% | 9.65% | +74.2% |
Q1 2022 | $39,994,000 | -14.6% | 1,100,542 | +9.5% | 5.54% | +13.3% |
Q4 2021 | $46,831,000 | -31.7% | 1,004,742 | -25.9% | 4.89% | +17.6% |
Q3 2021 | $68,587,000 | +24.5% | 1,356,542 | +1.1% | 4.16% | +81.3% |
Q2 2021 | $55,107,000 | +80.1% | 1,342,442 | +27.3% | 2.29% | +79.5% |
Q1 2021 | $30,594,000 | +40.1% | 1,054,242 | +36.0% | 1.28% | +10.0% |
Q4 2020 | $21,831,000 | -27.0% | 775,242 | -20.0% | 1.16% | -42.3% |
Q3 2020 | $29,909,000 | -41.4% | 968,862 | -19.2% | 2.02% | -49.2% |
Q2 2020 | $51,007,000 | – | 1,198,483 | – | 3.96% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |